REGENXBIO Inc.RGNXNASDAQ
LOADING
|||
Operating Income Contraction
Trending higher, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-233.35M
↓ 146% below average
Average (9y)
$-94.89M
Historical baseline
Range
High:$159.98M
Low:$-268.13M
CAGR
+29.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-233.35M | +13.0% |
| 2023 | $-268.13M | -2.0% |
| 2022 | $-262.88M | -264.3% |
| 2021 | $159.98M | +234.2% |
| 2020 | $-119.23M | +20.0% |
| 2019 | $-149.00M | -269.1% |
| 2018 | $88.10M | +216.1% |
| 2017 | $-75.89M | -16.1% |
| 2016 | $-65.34M | -182.4% |
| 2015 | $-23.14M | - |